Glenmark Latest Generic Drug Maker Charged in Price-Fixing Probe
- July 10, 2020
Glenmark Pharmaceutical is the fifth company to face allegations that it participated in a far-reaching conspiracy to fix prices for generic drugs, the Department of Justice (DOJ) announced June 30.
ARTICLE TAGS
You must be logged in to access this content.